134 related articles for article (PubMed ID: 118835)
1. Cellular immunity in patients with meningococcal disease and in vaccinated subjects.
Greenwood BM; Oduloju AJ; Ade-Serrano MA
Clin Exp Immunol; 1979 Oct; 38(1):9-15. PubMed ID: 118835
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal vaccines.
Bethell D; Pollard AJ
Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
[TBL] [Abstract][Full Text] [Related]
3. Control of meningococcal meningitis with meningococcal vaccines.
Artenstein MS
Yale J Biol Med; 1975 Jul; 48(3):197-200. PubMed ID: 808913
[TBL] [Abstract][Full Text] [Related]
4. Right age for Meningococcal vaccine.
John TJ
Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
[No Abstract] [Full Text] [Related]
5. [Immune response to meningococci].
Flaegstad T
Tidsskr Nor Laegeforen; 1989 Jan; 109(1):33-6. PubMed ID: 2492123
[TBL] [Abstract][Full Text] [Related]
6. An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine.
Rosenqvist E; Tjade T; Frøholm LO; Frasch CE
NIPH Ann; 1983 Dec; 6(2):139-49. PubMed ID: 6427704
[TBL] [Abstract][Full Text] [Related]
7. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
8. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
[TBL] [Abstract][Full Text] [Related]
9. Safety of meningococcal polysaccharide vaccine serogroup "A" (Pilot Study).
Bahl MR
Med J Zambia; 1975 Dec-1976 Jan; 9(6):166. PubMed ID: 818845
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.
McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P
J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739
[TBL] [Abstract][Full Text] [Related]
11. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
12. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
Wu C
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
[No Abstract] [Full Text] [Related]
13. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
Krizova P; Musilek M
Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
[TBL] [Abstract][Full Text] [Related]
14. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
[TBL] [Abstract][Full Text] [Related]
15. Defences against meningococcal infections.
Lancet; 1985 Oct; 2(8461):929-30. PubMed ID: 2865427
[No Abstract] [Full Text] [Related]
16. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
García Moreno J; Prat Miranda MS; Vicent P; Calderón B
Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
[No Abstract] [Full Text] [Related]
17. The role of complement in anti-bacterial defence.
D'Amelio R; Biselli R
Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
[TBL] [Abstract][Full Text] [Related]
18. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A].
Yuan CD
Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682
[No Abstract] [Full Text] [Related]
19. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].
Krízová P; Vlcková J; Bobák M
Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antibody response in meningococcal patients, contacts and vaccinees in north India.
Rao B; Ayyagari A; Sharma M
Trop Geogr Med; 1991; 43(1-2):111-3. PubMed ID: 1750098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
